84. サルコイドーシス Sarcoidosis Clinical trials / Disease details

臨床試験数 : 149 / 薬物数 : 227 - (DrugBank : 81) / 標的遺伝子数 : 82 - 標的パスウェイ数 : 167

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00731757 (ClinicalTrials.gov)	May 2009	6/8/2008	Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis	A Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumabin the Treatment o ...	Sarcoidosis;Cutaneous Sarcoidosis	Drug: Humira	Wright State University	Stanford University	Withdrawn	18 Years	N/A	All	0	Phase 2	United States
2	NCT00690911 (ClinicalTrials.gov)	August 2007	2/6/2008	Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous Sarcoidosis	A Phase II, Multi-Center, Open Label Study to Determine the Efficacy of Adalimumabin the Treatment o ...	Sarcoidosis	Drug: adalimumab	Wake Forest University	NULL	Withdrawn	18 Years	N/A	All	0	Phase 2	United States
3	NCT00274352 (ClinicalTrials.gov)	September 2006	6/1/2006	A Study of Adalimumab to Treat Sarcoidosis of the Skin	A Double-Blind, Randomized, Placebo-Controlled Study of Adalimumabin the Treatment of Cutaneous Sarc ...	Sarcoidosis	Drug: adalimumab	Pariser, Robert J., M.D.	Abbott;Virginia Clinical Research, Inc.	Completed	18 Years	89 Years	Both	16	Phase 2	United States
4	EUCTR2006-001816-56-DK (EUCTR)	11/05/2006	28/04/2006	Can PET scan be used to assess disease activity in patients with sarcoidosis during treatment with a ...	Can PET scan be used to assess disease activity in patients with sarcoidosis during treatment with a ...	sarcoidosis	Trade Name: Humira Product Name: Humira	Rigshospitalet	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	10	Phase 2	Denmark
5	NCT00311246 (ClinicalTrials.gov)	April 2006	3/4/2006	Trial of Adalimumab in Progressive Sarcoidosis	A Prospective Open-Label Trial of Adalimumab in Progressive Sarcoidosis	Sarcoidosis	Drug: Adalimumab	University of Chicago	Abbott	Terminated	18 Years	85 Years	All	11	Phase 2	United States

First Previous1Next Last